Systemic carboplatin for retinoblastoma: change in tumour size over time

Background/aim: Chemotherapy for intraocular retinoblastoma is used to shrink individual retinal tumours to a size amenable to focal treatments. Quantitative data regarding retinal tumour response following treatment with primary systemic carboplatin are reported. Methods: Changes in area and larges...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abramson, D H, Lawrence, S D, Beaverson, K L, Lee, T C, Rollins, I S, Dunkel, I J
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2005 British Journal of Ophthalmology 2005
Assuntos:
Clinical Science - Extended Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1772963/
https://ncbi.nlm.nih.gov/pubmed/16299142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2005.072033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados